multiple-sclerosis-research.org
/1 month ago
Frexalimab AAN20226
Frexalimab is an indirect B cell inhibitor. It block the natural signal that a B cell gets from T cells and antigen presenting cells as it blocks the ligand (binding bit) to the CD...